Top compounds associated with response to LINC00675


Feature Type Standardized
Nominal ANOVA
mRNA austocystin d CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA YM-155 CTRPv2 pan-cancer AAC -0.17 4e-05
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA Doxorubicin gCSI pan-cancer AAC -0.22 0.0001
mRNA niclosamide CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA bid1870 gCSI pan-cancer AAC -0.21 0.0005
mRNA thapsigargin gCSI pan-cancer AAC -0.21 0.0009
mRNA Gemcitabine gCSI pan-cancer AAC -0.2 0.001
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
Download CSV